Spleen tyrosine kinase mediates innate and adaptive immune crosstalk in SARS‐CoV‐2 mRNA vaccination
Sebastian J. Theobald(University of Cologne), Jan Rybniker(Integrated Oncology (United States)), Ulrike Göbel(University of Cologne), Alexander Simonis(University of Cologne), Viktoria Kohlhas(Düsseldorf University Hospital), Manuel Koch(University Hospital Cologne), Sandra Winter(University of Cologne), Julie M Mudler(University of Cologne), Michael Hallek(Integrated Oncology (United States)), Marie‐Christine Albert(Cologne Excellence Cluster on Cellular Stress Responses in Aging Associated Diseases), Phuong‐Hien Nguyen(University of Cologne), Henning Walczak(CRUK Lung Cancer Centre of Excellence), Richard Acton(Babraham Institute), Anna‐Maria Hellmann(University of Cologne), Jakob J Malin(University of Cologne)
Cited by 21
Related Papers
iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL
|Blood|2018|1.7k
Idelalisib and Rituximab in Relapsed Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2014|1.7k
Rethinking ovarian cancer: recommendations for improving outcomes
|Nature reviews. Cancer|2011|1.5k